123
123
May 3, 2014
05/14
by
CNBC
tv
eye 123
favorite 0
quote 0
biomarin, insmed, lexion and vertex. pharma, if general, has seen quite a lot.ne of the names did stick out, vertex. several days or after we saw above average volume. now they did announce earnings. you might think that's what this is about. except what we were seeing is a lot of activity in the july 80 calls. we are talking a nearly 30% move to the upside on a stock that usually moves 3% on earnings. it isn't clear that's what they were betting on. they are going out further. it seems if anybody is betting on an upside move on these, it looks like vertex is the one they are using now. >> do you use unusual activity as your did to the next target? >> in space like this, it can be. most investors will never know what the dates are and the probabilitys of a binary event happening on one of these names. you know, a lot of times, you know, investors don't care what they're paying as far as implied volatility. it is important to keep an eye on. i don't chase it at all. >> coming up federal government, a huge event for twitter. we will tell you why when options actio
biomarin, insmed, lexion and vertex. pharma, if general, has seen quite a lot.ne of the names did stick out, vertex. several days or after we saw above average volume. now they did announce earnings. you might think that's what this is about. except what we were seeing is a lot of activity in the july 80 calls. we are talking a nearly 30% move to the upside on a stock that usually moves 3% on earnings. it isn't clear that's what they were betting on. they are going out further. it seems if...
135
135
May 4, 2014
05/14
by
CNBC
tv
eye 135
favorite 0
quote 0
the last one we talked about before, vertex pharmaceuticals. they have a cystic fibrosis combo.g buy. >> what dealer are options are traders betting on? we go to the sherlock of puts and calls, david ka russo of volatility. >> they mentioned nine potential takeover candidates and four of them i'll mention right now, biomarin and vertex and ale ale. on april 9th they traded six times their average daily call volume. yesterday kben, three times the average call volume. you might think advanced earnings is what this is about. what we were seeing is a lot of activity in the july 80 calls and those are about $9, a 30% move to the upside on a stock that usually moves about 3% on earnings and pretty clear that isn't what they were betting on and going out a little further than the earnings date. it seems if anybody is betting on an upside move, it looks like vertex is the one. >> do you use unusual activity as your guide to what could be the next target? >> in a space like this, it can be. most investors at home never know when the dates are or what the probabilities of some sort of bi
the last one we talked about before, vertex pharmaceuticals. they have a cystic fibrosis combo.g buy. >> what dealer are options are traders betting on? we go to the sherlock of puts and calls, david ka russo of volatility. >> they mentioned nine potential takeover candidates and four of them i'll mention right now, biomarin and vertex and ale ale. on april 9th they traded six times their average daily call volume. yesterday kben, three times the average call volume. you might think...
58
58
May 2, 2014
05/14
by
CNBC
tv
eye 58
favorite 0
quote 0
vertex and alexion are among the bigger names.look and trying to see where there was unusual options activity. one of the names did stick out and that was vertex. they traded six times their average call volume. and then yesterday again about three times the average daily call volume. now they did announce earnings and you might think that's what this is about except what we were seeing was a lot of act in the july 80 calls. those things are about $9. so we're talking about a nearly 30% move to the upside on a stock that moves about 3% on earnings. it's clear that isn't what they were betting on and they're going out a little bit further. so it seems if anybody is betting on an upside move it looks like vertex is the one they're betting on now. >> do you use unusual activity is your guide to what could be the next target? >> in a space like this action it can be. most investors at home will never know when the dates are and what the probabilities of some sort of bionary event happening. so a lot of times investors don't care what
vertex and alexion are among the bigger names.look and trying to see where there was unusual options activity. one of the names did stick out and that was vertex. they traded six times their average call volume. and then yesterday again about three times the average daily call volume. now they did announce earnings and you might think that's what this is about except what we were seeing was a lot of act in the july 80 calls. those things are about $9. so we're talking about a nearly 30% move to...
49
49
May 17, 2014
05/14
by
ALJAZAM
tv
eye 49
favorite 0
quote 0
as long as i make the grid sufficiently fine, i can make everything i'm looking at line up with a vertex point. bottom line, that's 0 calculus does -- how calculus does. >> the change in the way you perceive everything. you had only gotten through prealgebra. how did you figure out that this went beyond how you were seeing things and you had become a math savant? >> i started drawing what i was seeing because i didn't have the vocabulary to say it. there is a way i draw the number pi at different values. you can draw pi and show how it's becoming smoother and it's describing a shape that is forever approaching a circle. but when you try to describe it without a drawing, it just -- my explanation falls short. and at the time i had no technical mathematical skills. i started drawing it and showing it to people so i could better explain it. i found out without any technical learning or any technical math courses i was able to explain it to people and they all understood it. eventually went back to school to learn traditional math to draw the lines. >> you had some negative effects. >> 300 o
as long as i make the grid sufficiently fine, i can make everything i'm looking at line up with a vertex point. bottom line, that's 0 calculus does -- how calculus does. >> the change in the way you perceive everything. you had only gotten through prealgebra. how did you figure out that this went beyond how you were seeing things and you had become a math savant? >> i started drawing what i was seeing because i didn't have the vocabulary to say it. there is a way i draw the number...
250
250
May 1, 2014
05/14
by
CNBC
tv
eye 250
favorite 0
quote 0
vertex pharmaceuticals climbing up 9% in the after-hours.ently up toward session highs, after-hours highs up 3%. >> josh, you were impressed with the market response on linkedin. lot of volatility there. >> yeah. it looks like once they had a chance to kind of catch their breath an figure out -- because we give a summary judgment to the headline number. they missed or the guidance is a little bit light. then there is a huge reaction. actual investors step in, relieve the traders from active duty, they say all right, this is what we are willing to pay for the stock. >> as bill said, he wasn't going to use it and that's what happened. >> or maybe they announce they will allot cat photos. is there longer term, i don't know how young their audience is but i teach a class at colombl . graduates students are required to be on. if it is tied in to all the recent graduates and they are forced to do it, then we'll continue to see growth in this company. >> linkedin has a very -- >> on the other hand, this is the largest graduating class from our univ
vertex pharmaceuticals climbing up 9% in the after-hours.ently up toward session highs, after-hours highs up 3%. >> josh, you were impressed with the market response on linkedin. lot of volatility there. >> yeah. it looks like once they had a chance to kind of catch their breath an figure out -- because we give a summary judgment to the headline number. they missed or the guidance is a little bit light. then there is a huge reaction. actual investors step in, relieve the traders...